Recent Posts
- FDA Okays Blood Test for Ovarian Cancer
- Replication At DNA Damage Sites Highlights Fanconi Anemia And Breast Cancer Proteins
- ASCO To Hold Annual Meeting In Chicago For The Next Ten Years: City Seen As Best Choice To Host Meeting That Continues To Grow
- Protein Partnership Leads To Pediatric Tumor Regression
- ASCO Awarded CEO Cancer Gold Standard: Achievement Underscores Organization’s Commitment To The Health And Well-Being Of Its Employees
Random Posts
- Surveillance is Safe for Probable Benign Breast Masses (CME/CE)
- ECCO-ESMO: No Benefit for Adjuvant Radiation in Brain Metastasis (CME/CE)
- Advanced Pediatric Neurosurgery Program Focuses On Children's Brain Tumors, Other Nervous System Disorders
- Tumor Perfusion Assessed By Dynamic Contrast-Enhanced MRI (DCE MRI) Correlates To The Grading Of Renal Cell Carcinoma
- Centralized Review Process Markedly Expedites Approval Of Cancer Clinical Trials
- Cervical Cancer Risk For Women Over 50
- Hunt For Blood Test To Determine Melanoma Survival Rates
- Aggressive Infection Control Program Protects Cancer Patients From Acquiring Clinic-Based H1N1 Influenza
- FDA Approves Drug For Treatment Of Aggressive Brain Cancer
- Physical Therapists Walk To Raise Funds For Free Mammograms For Alexandria Women
Prescription Cancer Drugs
Shedding Light On Cancer Cells
Posted by: admin in Prescription Cancer Drugs on September 28th, 2009
Scientists label cells with coloured or glowing chemicals to observe how basic cellular activities differ between healthy and cancerous cells. Existing techniques for labelling cells are either too slow or too toxic to perform on live cells. Now, a study reviewed by Philip Dawson, a member of Faculty of 1000 Biology and leading authority in chemistry and cell biology, describes a novel labelling technique that uses a chemical reaction to make live cancer cells light up quickly and safely.
Researchers at Massachusetts General Hospital developed a two-step process to specifically tag cancer cells. First, chemically modified antibodies home in on cancer cells. Then a chemical reaction called cycloaddition transfers a dye onto the antibody making the cancer cells glow when viewed through a microscope.
The novel cycloaddition reaction is fast, very specific, and requires minimal manipulation of the cells. Dawson comments that, in combining antibody binding with the cycloaddition, “low signal-to-noise ratios are achieved”. This new labelling technique could be used to track the location and activity of anti-cancer drugs, the location of cancer-specific proteins within the cell, or to visualize cancer cells inside a living organism.
Dawson concludes that cycloaddition will allow scientists to observe live cancer cells in the body, leading to a better understanding of cancer’s basic processes.
The full text of this article is available at http://f1000biology.com/article/nztqpbh7bsrf6vb/id/1164570
Source:
Steve Pogonowski
Faculty of 1000: Biology and Medicine
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.